Astrana Health Inc Net Assets
Astrana Health Inc net assets. Based on the latest financial reports, Astrana Health Inc (ASTH) has net assets worth $598.58 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.28 Billion) and total liabilities ($1.68 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset momentum of Astrana Health Inc to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $598.58 Million |
| % of Total Assets | 26.23% |
| Annual Growth Rate | N/A |
| 5-Year Change | 9.34% |
| 10-Year Change | 206408.91% |
| Growth Volatility | 37288.37 |
Net Assets of Astrana Health Inc (2001–2025)
Net assets of Astrana Health Inc from 2001 to 2025. This chart illustrates how Astrana Health Inc's net assets have evolved over time, based on quarterly financial data. See Astrana Health Inc net asset quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Astrana Health Inc (2001–2025)
The table below shows the annual net assets of Astrana Health Inc from 2001 to 2025. For live market cap and overall valuation, see market cap of Astrana Health Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $558.33 Million | +8.59% |
| 2024-12-31 | $514.17 Million | +25.17% |
| 2023-12-31 | $410.77 Million | -26.46% |
| 2022-12-31 | $558.55 Million | +9.38% |
| 2021-12-31 | $510.64 Million | +14.71% |
| 2020-12-31 | $445.15 Million | +23.29% |
| 2019-12-31 | $361.06 Million | -11.21% |
| 2018-12-31 | $406.66 Million | +20.92% |
| 2017-12-31 | $336.31 Million | +124290.89% |
| 2016-12-31 | $270.37K | -96.84% |
| 2015-12-31 | $8.55 Million | +626.83% |
| 2014-12-31 | $-1.62 Million | 0.00% |
| 2013-12-31 | $-1.62 Million | -314.73% |
| 2012-12-31 | $-391.38K | +7.08% |
| 2011-12-31 | $-421.22K | -406.31% |
| 2010-12-31 | $-83.19K | -79.32% |
| 2009-12-31 | $-46.39K | +80.74% |
| 2008-12-31 | $-240.91K | -1257.92% |
| 2007-12-31 | $-17.74K | +78.39% |
| 2006-12-31 | $-82.09K | -50.33% |
| 2005-12-31 | $-54.61K | -32.32% |
| 2004-12-31 | $-41.27K | -32.36% |
| 2003-12-31 | $-31.18K | -- |
| 2001-12-31 | $0.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to Astrana Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 30900201500.0% over the analyzed period, indicating profitable operations and earnings retention.
Astrana Health Inc Net Assets Breakdown (December 2025)
Astrana Health Inc net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $308.38 Million | 39.57% |
| Common Stock | $49.00K | 0.01% |
| Other Components | $470.86 Million | 60.42% |
| Total Equity | $779.29 Million | 100.00% |
Astrana Health Inc Competitors by Market Cap
The table below lists competitors of Astrana Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
China TransInfo Technology Co Ltd
SHE:002373
|
$1.82 Billion |
|
Brightstar Lottery PLC
NYSE:BRSL
|
$1.82 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
$1.82 Billion |
|
Diversified Healthcare Trust
NASDAQ:DHC
|
$1.83 Billion |
|
Monadelphous Group Ltd
F:8MP
|
$1.82 Billion |
|
ZAI LAB LTD0000006
F:1ZLB
|
$1.82 Billion |
|
Hoist Finance AB
ST:HOFI
|
$1.82 Billion |
|
Ams AG
SW:AMS
|
$1.82 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Astrana Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 712,720,000 to 779,291,000, a change of 66,571,000 (9.3%).
- Net income of 22,487,000 contributed positively to equity growth.
- Dividend payments of 7,885,000 reduced retained earnings.
- Share repurchases of 15,429,000 reduced equity.
- Other factors increased equity by 67,398,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $22.49 Million | +2.89% |
| Dividends Paid | $7.88 Million | -1.01% |
| Share Repurchases | $15.43 Million | -1.98% |
| Other Changes | $67.40 Million | +8.65% |
| Total Change | $- | 9.34% |
Book Value vs Market Value Analysis
This analysis compares Astrana Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.33x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $0.00 | $36.73 | x |
| 2003-12-31 | $-1.78 | $36.73 | x |
| 2004-12-31 | $-2.36 | $36.73 | x |
| 2005-12-31 | $-3.12 | $36.73 | x |
| 2006-12-31 | $-4.69 | $36.73 | x |
| 2007-12-31 | $-0.06 | $36.73 | x |
| 2008-12-31 | $-0.10 | $36.73 | x |
| 2009-12-31 | $-0.02 | $36.73 | x |
| 2010-12-31 | $-0.03 | $36.73 | x |
| 2011-12-31 | $-0.14 | $36.73 | x |
| 2012-12-31 | $-0.11 | $36.73 | x |
| 2013-12-31 | $-0.35 | $36.73 | x |
| 2014-12-31 | $-0.33 | $36.73 | x |
| 2015-12-31 | $1.11 | $36.73 | x |
| 2016-12-31 | $0.04 | $36.73 | x |
| 2017-12-31 | $5.58 | $36.73 | x |
| 2018-12-31 | $4.76 | $36.73 | x |
| 2019-12-31 | $5.26 | $36.73 | x |
| 2020-12-31 | $8.83 | $36.73 | x |
| 2021-12-31 | $9.87 | $36.73 | x |
| 2022-12-31 | $11.90 | $36.73 | x |
| 2023-12-31 | $13.05 | $36.73 | x |
| 2024-12-31 | $14.78 | $36.73 | x |
| 2025-12-31 | $15.78 | $36.73 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Astrana Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.89%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.71%
- • Asset Turnover: 1.43x
- • Equity Multiplier: 2.85x
- Recent ROE (2.89%) is above the historical average (-142.24%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.96K |
| 2003 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.69K |
| 2004 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.96K |
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-7.88K |
| 2006 | 0.00% | 0.00% | 0.00x | 0.00x | $-19.27K |
| 2007 | 0.00% | -36.65% | 1.00x | 0.00x | $-34.88K |
| 2008 | 0.00% | -84.34% | 2.55x | 0.00x | $-867.72K |
| 2009 | 0.00% | -8.03% | 1.87x | 0.00x | $-191.44K |
| 2010 | 0.00% | -4.01% | 3.10x | 0.00x | $-148.01K |
| 2011 | 0.00% | -14.09% | 3.75x | 0.00x | $-678.22K |
| 2012 | 0.00% | -114.51% | 2.41x | 0.00x | $-8.87 Million |
| 2013 | 0.00% | -47.88% | 1.11x | 0.00x | $-4.86 Million |
| 2014 | 0.00% | -5.46% | 3.48x | 0.00x | $-1.64 Million |
| 2015 | -160.87% | -21.21% | 2.25x | 3.37x | $-9.92 Million |
| 2016 | -3317.63% | -15.62% | 2.78x | 76.36x | $-9.00 Million |
| 2017 | 16.13% | 7.21% | 0.73x | 3.07x | $9.81 Million |
| 2018 | 6.00% | 2.08% | 1.01x | 2.84x | $-7.22 Million |
| 2019 | 7.37% | 2.52% | 0.77x | 3.80x | $-5.04 Million |
| 2020 | -7.18% | -6.42% | 0.45x | 2.47x | $-56.83 Million |
| 2021 | 15.38% | 8.91% | 0.89x | 1.94x | $24.11 Million |
| 2022 | 8.33% | 3.95% | 1.18x | 1.78x | $-9.09 Million |
| 2023 | 9.89% | 4.38% | 1.49x | 1.52x | $-704.80K |
| 2024 | 6.05% | 2.12% | 1.50x | 1.90x | $-28.12 Million |
| 2025 | 2.89% | 0.71% | 1.43x | 2.85x | $-55.44 Million |
Industry Comparison
This section compares Astrana Health Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $458,284,273
- Average return on equity (ROE) among peers: -1.90%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Astrana Health Inc (ASTH) | $598.58 Million | 0.00% | 2.81x | $1.82 Billion |
| Acadia Healthcare Company Inc (ACHC) | $1.69 Billion | 7.07% | 1.54x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $574.34 Million | 7.86% | 0.65x | $1.69 Billion |
| agilon health Inc (AGL) | $-284.73 Million | 0.00% | 0.00x | $1.47 Billion |
| Airsculpt Technologies Inc (AIRS) | $83.99 Million | -5.33% | 1.43x | $118.24 Million |
| Amedisys Inc (AMED) | $410.44 Million | -0.74% | 0.67x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $706.62 Million | -20.80% | 2.42x | $624.22 Million |
| American Shared Hospital Service (AMS) | $6.00 Million | 15.00% | 5.00x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $325.24 Million |
| Ardent Health Partners, Inc. (ARDT) | $711.84 Million | -20.09% | 2.86x | $1.66 Billion |
About Astrana Health Inc
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health … Read more